A big first step in our strategy to test low-dose IL-2 as a potential treatment for patients with ischemic heart disease | Cambridge Cardiovascular

skip to content

Submitted by Vicky Yee K Reid on Tue, 30/11/2021 - 15:53

Congratulations Tian Zhao, Ziad Mallat and all the collaborators. More on our approach from the bench to the bedside just published in NEJM Evidence. Click the link to see the article 'Regulatory T-Cell Response to Low-Dose

Interleukin-22 in Ischemic Heart Disease'

We connect cardiovascular researchers in Cambridge and beyond.

For inquiries about our research, please contact Dr Jane Sugars

For enquiries about our website or joining Cambridge Cardiovascular, please contact Denise Hatherly

Find us on LinkedIn

Follow us on X

Please follow us here on X for local news about research, events, funding calls, and open positions.

You must be logged into X to see our feed here:

Tweets by Cambridgecardio

Our Newsletter

Click on the image below for previous Newsletters and for our Email sign up form

Find us on YouTube